Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice

Lydie Viatte,Jeanne-Claire Lesbordes-Brion,Dan-Qing Lou,Myriam Bennoun,Gaël Nicolas,Axel Kahn,François Canonne-Hergaux,Sophie Vaulont
DOI: https://doi.org/10.1182/blood-2004-12-4608
IF: 20.3
2005-06-15
Blood
Abstract:Evidence is accumulating that hepcidin, a liver regulatory peptide, could be the common pathogenetic denominator of all forms of iron overload syndromes including HFE-related hemochromatosis, the most prevalent genetic disorder characterized by inappropriate iron absorption. To understand the mechanisms whereby hepcidin controls iron homeostasis in vivo, we have analyzed the level of iron-related proteins by Western blot and immunohistochemistry in hepcidin-deficient mice, a mouse model of severe hemochromatosis. These mice showed important increased levels of duodenal cytochrome b (Dcytb), divalent metal transporter 1 (DMT1), and ferroportin compared with control mice. Interestingly, the level of ferroportin was coordinately up-regulated in the duodenum, the spleen, and the liver (predominantly in the Kupffer cells). Finally, we also evidenced a decrease of ceruloplasmin in the liver of hepcidin-deficient mice. We hypothesized that the deregulation of these proteins might be central in the pathogenesis of iron overload, providing key therapeutic targets for iron disorders.
What problem does this paper attempt to address?